Report Detail

Request for Sample of this report

Pharma & Healthcare Global Oral Anti-Diabetic Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3808102
    • |
  • 13 August, 2024
    • |
  • Global
    • |
  • 117 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Anti-Diabetic Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Oral Anti-Diabetic Drug industry chain, the market status of Hospital (Glimepiride, Gliclazide), Research Institual (Glimepiride, Gliclazide), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Anti-Diabetic Drug.
Regionally, the report analyzes the Oral Anti-Diabetic Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Anti-Diabetic Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Anti-Diabetic Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Anti-Diabetic Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Tons), revenue generated, and market share of different by Type (e.g., Glimepiride, Gliclazide).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Anti-Diabetic Drug market.
Regional Analysis: The report involves examining the Oral Anti-Diabetic Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Anti-Diabetic Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Anti-Diabetic Drug:
Company Analysis: Report covers individual Oral Anti-Diabetic Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Anti-Diabetic Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Research Institual).
Technology Analysis: Report covers specific technologies relevant to Oral Anti-Diabetic Drug. It assesses the current state, advancements, and potential future developments in Oral Anti-Diabetic Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Anti-Diabetic Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral Anti-Diabetic Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Glimepiride
Gliclazide
Glyburide
Others
Market segment by Application
Hospital
Research Institual
Major players covered
Takeda
Pfizer
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
Merck And Co.
AstraZeneca
Bristol Myers Squibb
Novartis
Sanofi
Abbott
Biocon
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Anti-Diabetic Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Anti-Diabetic Drug, with price, sales, revenue and global market share of Oral Anti-Diabetic Drug from 2019 to 2024.
Chapter 3, the Oral Anti-Diabetic Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anti-Diabetic Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oral Anti-Diabetic Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Anti-Diabetic Drug.
Chapter 14 and 15, to describe Oral Anti-Diabetic Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Oral Anti-Diabetic Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oral Anti-Diabetic Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Glimepiride
    • 1.3.3 Gliclazide
    • 1.3.4 Glyburide
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Oral Anti-Diabetic Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Research Institual
  • 1.5 Global Oral Anti-Diabetic Drug Market Size & Forecast
    • 1.5.1 Global Oral Anti-Diabetic Drug Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Oral Anti-Diabetic Drug Sales Quantity (2019-2030)
    • 1.5.3 Global Oral Anti-Diabetic Drug Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Takeda
    • 2.1.1 Takeda Details
    • 2.1.2 Takeda Major Business
    • 2.1.3 Takeda Oral Anti-Diabetic Drug Product and Services
    • 2.1.4 Takeda Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Takeda Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Oral Anti-Diabetic Drug Product and Services
    • 2.2.4 Pfizer Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 Eli Lilly
    • 2.3.1 Eli Lilly Details
    • 2.3.2 Eli Lilly Major Business
    • 2.3.3 Eli Lilly Oral Anti-Diabetic Drug Product and Services
    • 2.3.4 Eli Lilly Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Eli Lilly Recent Developments/Updates
  • 2.4 Janssen Pharmaceuticals
    • 2.4.1 Janssen Pharmaceuticals Details
    • 2.4.2 Janssen Pharmaceuticals Major Business
    • 2.4.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product and Services
    • 2.4.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Janssen Pharmaceuticals Recent Developments/Updates
  • 2.5 Astellas
    • 2.5.1 Astellas Details
    • 2.5.2 Astellas Major Business
    • 2.5.3 Astellas Oral Anti-Diabetic Drug Product and Services
    • 2.5.4 Astellas Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Astellas Recent Developments/Updates
  • 2.6 Boehringer Ingelheim
    • 2.6.1 Boehringer Ingelheim Details
    • 2.6.2 Boehringer Ingelheim Major Business
    • 2.6.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Product and Services
    • 2.6.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.7 Merck And Co.
    • 2.7.1 Merck And Co. Details
    • 2.7.2 Merck And Co. Major Business
    • 2.7.3 Merck And Co. Oral Anti-Diabetic Drug Product and Services
    • 2.7.4 Merck And Co. Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Merck And Co. Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Oral Anti-Diabetic Drug Product and Services
    • 2.8.4 AstraZeneca Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Bristol Myers Squibb
    • 2.9.1 Bristol Myers Squibb Details
    • 2.9.2 Bristol Myers Squibb Major Business
    • 2.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Product and Services
    • 2.9.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bristol Myers Squibb Recent Developments/Updates
  • 2.10 Novartis
    • 2.10.1 Novartis Details
    • 2.10.2 Novartis Major Business
    • 2.10.3 Novartis Oral Anti-Diabetic Drug Product and Services
    • 2.10.4 Novartis Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Novartis Recent Developments/Updates
  • 2.11 Sanofi
    • 2.11.1 Sanofi Details
    • 2.11.2 Sanofi Major Business
    • 2.11.3 Sanofi Oral Anti-Diabetic Drug Product and Services
    • 2.11.4 Sanofi Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Sanofi Recent Developments/Updates
  • 2.12 Abbott
    • 2.12.1 Abbott Details
    • 2.12.2 Abbott Major Business
    • 2.12.3 Abbott Oral Anti-Diabetic Drug Product and Services
    • 2.12.4 Abbott Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Abbott Recent Developments/Updates
  • 2.13 Biocon
    • 2.13.1 Biocon Details
    • 2.13.2 Biocon Major Business
    • 2.13.3 Biocon Oral Anti-Diabetic Drug Product and Services
    • 2.13.4 Biocon Oral Anti-Diabetic Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Biocon Recent Developments/Updates

3 Competitive Environment: Oral Anti-Diabetic Drug by Manufacturer

  • 3.1 Global Oral Anti-Diabetic Drug Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Oral Anti-Diabetic Drug Revenue by Manufacturer (2019-2024)
  • 3.3 Global Oral Anti-Diabetic Drug Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Oral Anti-Diabetic Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Oral Anti-Diabetic Drug Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Oral Anti-Diabetic Drug Manufacturer Market Share in 2023
  • 3.5 Oral Anti-Diabetic Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Oral Anti-Diabetic Drug Market: Region Footprint
    • 3.5.2 Oral Anti-Diabetic Drug Market: Company Product Type Footprint
    • 3.5.3 Oral Anti-Diabetic Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oral Anti-Diabetic Drug Market Size by Region
    • 4.1.1 Global Oral Anti-Diabetic Drug Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Oral Anti-Diabetic Drug Consumption Value by Region (2019-2030)
    • 4.1.3 Global Oral Anti-Diabetic Drug Average Price by Region (2019-2030)
  • 4.2 North America Oral Anti-Diabetic Drug Consumption Value (2019-2030)
  • 4.3 Europe Oral Anti-Diabetic Drug Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Oral Anti-Diabetic Drug Consumption Value (2019-2030)
  • 4.5 South America Oral Anti-Diabetic Drug Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Oral Anti-Diabetic Drug Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Oral Anti-Diabetic Drug Sales Quantity by Type (2019-2030)
  • 5.2 Global Oral Anti-Diabetic Drug Consumption Value by Type (2019-2030)
  • 5.3 Global Oral Anti-Diabetic Drug Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Oral Anti-Diabetic Drug Sales Quantity by Application (2019-2030)
  • 6.2 Global Oral Anti-Diabetic Drug Consumption Value by Application (2019-2030)
  • 6.3 Global Oral Anti-Diabetic Drug Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Oral Anti-Diabetic Drug Sales Quantity by Type (2019-2030)
  • 7.2 North America Oral Anti-Diabetic Drug Sales Quantity by Application (2019-2030)
  • 7.3 North America Oral Anti-Diabetic Drug Market Size by Country
    • 7.3.1 North America Oral Anti-Diabetic Drug Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Oral Anti-Diabetic Drug Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Oral Anti-Diabetic Drug Sales Quantity by Type (2019-2030)
  • 8.2 Europe Oral Anti-Diabetic Drug Sales Quantity by Application (2019-2030)
  • 8.3 Europe Oral Anti-Diabetic Drug Market Size by Country
    • 8.3.1 Europe Oral Anti-Diabetic Drug Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Oral Anti-Diabetic Drug Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oral Anti-Diabetic Drug Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Oral Anti-Diabetic Drug Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Oral Anti-Diabetic Drug Market Size by Region
    • 9.3.1 Asia-Pacific Oral Anti-Diabetic Drug Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Oral Anti-Diabetic Drug Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Oral Anti-Diabetic Drug Sales Quantity by Type (2019-2030)
  • 10.2 South America Oral Anti-Diabetic Drug Sales Quantity by Application (2019-2030)
  • 10.3 South America Oral Anti-Diabetic Drug Market Size by Country
    • 10.3.1 South America Oral Anti-Diabetic Drug Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Oral Anti-Diabetic Drug Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oral Anti-Diabetic Drug Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Oral Anti-Diabetic Drug Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Oral Anti-Diabetic Drug Market Size by Country
    • 11.3.1 Middle East & Africa Oral Anti-Diabetic Drug Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Oral Anti-Diabetic Drug Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Oral Anti-Diabetic Drug Market Drivers
  • 12.2 Oral Anti-Diabetic Drug Market Restraints
  • 12.3 Oral Anti-Diabetic Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oral Anti-Diabetic Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oral Anti-Diabetic Drug
  • 13.3 Oral Anti-Diabetic Drug Production Process
  • 13.4 Oral Anti-Diabetic Drug Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oral Anti-Diabetic Drug Typical Distributors
  • 14.3 Oral Anti-Diabetic Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oral Anti-Diabetic Drug. Industry analysis & Market Report on Oral Anti-Diabetic Drug is a syndicated market report, published as Global Oral Anti-Diabetic Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Oral Anti-Diabetic Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo